These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18704016)

  • 21. L-Arginine supplementation in sepsis: beneficial or harmful?
    Kalil AC; Danner RL
    Curr Opin Crit Care; 2006 Aug; 12(4):303-8. PubMed ID: 16810039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oh no, not nitric oxide!
    Bhagat K
    Cent Afr J Med; 1999 Jun; 45(6):160-3. PubMed ID: 10695189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exogenous arginine in sepsis.
    Luiking YC; Deutz NE
    Crit Care Med; 2007 Sep; 35(9 Suppl):S557-63. PubMed ID: 17713409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The vasopressin and copeptin response to infection, severe sepsis, and septic shock.
    Jochberger S; Dörler J; Luckner G; Mayr VD; Wenzel V; Ulmer H; Morgenthaler NG; Hasibeder WR; Dünser MW
    Crit Care Med; 2009 Feb; 37(2):476-82. PubMed ID: 19114902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver perfusion in sepsis, septic shock, and multiorgan failure.
    Spapen H
    Anat Rec (Hoboken); 2008 Jun; 291(6):714-20. PubMed ID: 18484618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of potassium channels in regulation of rat coronary arteriole tone.
    Wu GB; Zhou EX; Qing DX; Li J
    Eur J Pharmacol; 2009 Oct; 620(1-3):57-62. PubMed ID: 19686727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Research progress of methylene blue in the treatment of sepsis and septic shock].
    Xue J; Lou X; Chen G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Nov; 33(11):1384-1387. PubMed ID: 34980315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HMGB1 in the immunology of sepsis (not septic shock) and arthritis.
    Czura CJ; Yang H; Amella CA; Tracey KJ
    Adv Immunol; 2004; 84():181-200. PubMed ID: 15246253
    [No Abstract]   [Full Text] [Related]  

  • 29. [Severe sepsis and septic shock: crossroad between inflammation and coagulation].
    Jiménez Ortiz JL; Labarta Monzón L; Armengol Sáez S
    Med Clin (Barc); 2002 Jan; 118(2):78. PubMed ID: 11809155
    [No Abstract]   [Full Text] [Related]  

  • 30. Metabolism modulators in sepsis: the abnormal pituitary response.
    Maxime V; Siami S; Annane D
    Crit Care Med; 2007 Sep; 35(9 Suppl):S596-601. PubMed ID: 17713415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular alterations in septic shock.
    Vincent JL
    J Antimicrob Chemother; 1998 Jan; 41 Suppl A():9-15. PubMed ID: 9511081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Controversies in septic shock].
    Dhainaut JF; Marin N
    Rev Prat; 1999 Mar; 49(5):461-3. PubMed ID: 10358393
    [No Abstract]   [Full Text] [Related]  

  • 33. Toll-like receptor pathway signaling is differently regulated in neutrophils and peripheral mononuclear cells of patients with sepsis, severe sepsis, and septic shock.
    Koch A; Zacharowski K
    Crit Care Med; 2009 Jan; 37(1):346-7. PubMed ID: 19112297
    [No Abstract]   [Full Text] [Related]  

  • 34. Steroids and nitric oxide in sepsis.
    Fernandes D; Duma D; Assreuy J
    Front Biosci; 2008 Jan; 13():1698-710. PubMed ID: 17981661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Septic encephalopathy: inflammation in man and mouse.
    Jacob A; Brorson JR; Alexander JJ
    Neurochem Int; 2011 Mar; 58(4):472-6. PubMed ID: 21219956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Applying gases for microcirculatory and cellular oxygenation in sepsis: effects of nitric oxide, carbon monoxide, and hydrogen sulfide.
    Baumgart K; Radermacher P; Wagner F
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):168-76. PubMed ID: 19390245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe sepsis and septic shock at the Hajj: etiologies and outcomes.
    Baharoon S; Al-Jahdali H; Al Hashmi J; Memish ZA; Ahmed QA
    Travel Med Infect Dis; 2009 Jul; 7(4):247-52. PubMed ID: 19717109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous mediators in sepsis and septic shock.
    Beishuizen A; Vermes I; Haanen C
    Adv Clin Chem; 1998; 33():55-131. PubMed ID: 10086175
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pathophysiological mechanisms of the development of acute parenchymal pulmonary lesion in patients with sepsis and septic shock].
    Pestriakov EV; Iakovleva II; Moroz VV
    Anesteziol Reanimatol; 2003; (6):65-72. PubMed ID: 14991986
    [No Abstract]   [Full Text] [Related]  

  • 40. Nitric oxide in septic shock: directions for future therapy?
    Hon WM; Khoo HE; Moochhala S
    Ann Acad Med Singap; 1998 May; 27(3):414-21. PubMed ID: 9777090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.